U.S. Physical Therapy, Inc. (NYSE:USPH) Receives $109.00 Consensus Price Target from Brokerages

U.S. Physical Therapy, Inc. (NYSE:USPH - Get Free Report) has been assigned a consensus rating of "Buy" from the six analysts that are presently covering the company, Marketbeat reports. One analyst has rated the stock with a hold rating, four have issued a buy rating and one has given a strong buy rating to the company. The average twelve-month target price among brokerages that have updated their coverage on the stock in the last year is $109.00.

Several research analysts recently weighed in on the stock. William Blair restated a "market perform" rating on shares of U.S. Physical Therapy in a research report on Thursday, February 27th. StockNews.com downgraded U.S. Physical Therapy from a "hold" rating to a "sell" rating in a research report on Friday, February 28th. JPMorgan Chase & Co. decreased their price target on U.S. Physical Therapy from $120.00 to $110.00 and set an "overweight" rating on the stock in a report on Wednesday, March 19th. Citizens Jmp raised U.S. Physical Therapy to a "strong-buy" rating in a report on Monday, December 16th. Finally, Bank of America raised shares of U.S. Physical Therapy from a "neutral" rating to a "buy" rating and raised their target price for the company from $100.00 to $115.00 in a research note on Monday, December 16th.

Remove Ads

Insiders Place Their Bets

In other U.S. Physical Therapy news, COO Graham D. Reeve sold 1,730 shares of the stock in a transaction on Friday, March 7th. The shares were sold at an average price of $82.11, for a total value of $142,050.30. Following the sale, the chief operating officer now directly owns 7,168 shares in the company, valued at approximately $588,564.48. This trade represents a 19.44 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Company insiders own 1.70% of the company's stock.

Hedge Funds Weigh In On U.S. Physical Therapy

Several institutional investors and hedge funds have recently made changes to their positions in the company. CBIZ Investment Advisory Services LLC grew its stake in U.S. Physical Therapy by 59.8% in the fourth quarter. CBIZ Investment Advisory Services LLC now owns 326 shares of the company's stock valued at $29,000 after acquiring an additional 122 shares during the period. Point72 Asia Singapore Pte. Ltd. acquired a new position in shares of U.S. Physical Therapy in the 4th quarter valued at approximately $39,000. Venturi Wealth Management LLC increased its stake in U.S. Physical Therapy by 3,200.0% during the 4th quarter. Venturi Wealth Management LLC now owns 726 shares of the company's stock worth $64,000 after purchasing an additional 704 shares in the last quarter. Lazard Asset Management LLC acquired a new stake in U.S. Physical Therapy during the 4th quarter worth approximately $84,000. Finally, Pacer Advisors Inc. bought a new position in U.S. Physical Therapy in the fourth quarter valued at approximately $113,000.

U.S. Physical Therapy Price Performance

USPH traded up $0.11 during trading on Friday, hitting $72.47. The company's stock had a trading volume of 69,230 shares, compared to its average volume of 103,400. The company has a quick ratio of 1.78, a current ratio of 1.78 and a debt-to-equity ratio of 0.27. The stock has a market capitalization of $1.10 billion, a price-to-earnings ratio of 77.10, a price-to-earnings-growth ratio of 3.54 and a beta of 1.51. The firm's 50 day moving average price is $82.57 and its two-hundred day moving average price is $86.44. U.S. Physical Therapy has a 12 month low of $69.99 and a 12 month high of $112.52.

U.S. Physical Therapy (NYSE:USPH - Get Free Report) last issued its quarterly earnings results on Wednesday, February 26th. The company reported $0.65 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.69 by ($0.04). U.S. Physical Therapy had a return on equity of 8.11% and a net margin of 3.54%. The company had revenue of $180.45 million for the quarter, compared to analyst estimates of $173.10 million. Sell-side analysts forecast that U.S. Physical Therapy will post 2.67 earnings per share for the current fiscal year.

U.S. Physical Therapy Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, April 11th. Shareholders of record on Friday, March 14th will be paid a $0.45 dividend. This is a positive change from U.S. Physical Therapy's previous quarterly dividend of $0.44. The ex-dividend date is Friday, March 14th. This represents a $1.80 annualized dividend and a yield of 2.48%. U.S. Physical Therapy's dividend payout ratio is presently 97.83%.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.